Cite

HARVARD Citation

    Paul, S. et al. (2015). Letter: infliximab de‐escalation based on trough levels in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 42 (7), pp. 939-940. [Online]. 
  
Back to record